Jan Geissler speaks with ecancer at EHA 23 about the incorporation of patient reported outcomes (PROs) alongside clinical outcomes in haematology.

He discusses the essential consideration of patients priorities in treating and living with cancer, and the representation of patient advocacy groups at the conference.

Jan describes the enthusiasm for engaging patients in their treatment and wellbeing, and for incorporating PRO tools to improve clinicians abilities to offer the best care to an individual, and notes the many steps still ahead refining care.

Patient reported outcomes and quality of life were also discussed at ASCO 2018 by Dr Fabrice Denis.

ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.